{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T08:08:58Z","timestamp":1694765338042},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1007\/s11910-003-0038-5","type":"journal-article","created":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T08:26:57Z","timestamp":1180686417000},"page":"56-56","source":"Crossref","is-referenced-by-count":1,"title":["A Novel Potential Therapy for Spinal Muscular Atrophy"],"prefix":"10.1007","volume":"3","author":[{"given":"Michio","family":"Hirano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"38_CR1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11910-002-0058-6","volume":"2","author":"E Ciafaloni","year":"2002","unstructured":"Ciafaloni E, Sanders DB: Advances in myasthenia gravis. Curr Neurol Neurosci Rep 2002, 2:89\u201395.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"38_CR2","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.50.6.1778","volume":"50","author":"J Palace","year":"1998","unstructured":"Palace J, Newsom-Davis J, Lecky B: A randomized doubleblind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group. Neurology 1998, 50:1778\u20131783.","journal-title":"Neurology"},{"key":"38_CR3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1212\/WNL.55.1.7","volume":"55","author":"GS Gronseth","year":"2000","unstructured":"Gronseth GS, Barohn RJ: Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000, 55:7\u201315.","journal-title":"Neurology"},{"key":"38_CR4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","volume":"55","author":"A Jaretzki 3rd","year":"2000","unstructured":"Jaretzki A 3rd, Barohn RJ, Ernstoff RM, et al.: Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 2000, 55:16\u201323.","journal-title":"Neurology"},{"key":"38_CR5","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1126\/science.7910982","volume":"264","author":"J Melki","year":"1994","unstructured":"Melki J, Lefebvre S, Burglen L, et al.: De novo and inherited deletions of the 5q13 region in spinal muscular atrophies. Science 1994, 264:1474\u20131477.","journal-title":"Science"},{"key":"38_CR6","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1212\/WNL.57.8.1434","volume":"57","author":"JT Kissel","year":"2001","unstructured":"Kissel JT, McDermott MP, Mendell JR, et al.: Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy. Neurology 2001, 57:1434\u20131440.","journal-title":"Neurology"},{"key":"38_CR7","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1042\/cs0830615","volume":"83","author":"L Martineau","year":"1992","unstructured":"Martineau L, Horan MA, Rothwell NJ, Little RA: Salbutamol, a beta 2-adrenoceptor agonist, increases skeletal muscle strength in young men. Clin Sci (Lond) 1992, 83:615\u2013621.","journal-title":"Clin Sci (Lond)"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-003-0038-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-003-0038-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-003-0038-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:24:30Z","timestamp":1559420670000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-003-0038-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":7,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["38"],"URL":"https:\/\/doi.org\/10.1007\/s11910-003-0038-5","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}